BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 15021936)

  • 1. [IgA pemphigus. Successful treatment with mycophenolate mofetil].
    Burchardt T; Büchau A; Ruzicka T; Megahed M
    Hautarzt; 2004 Apr; 55(4):387-9. PubMed ID: 15021936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent.
    Esmaili N; Chams-Davatchi C; Valikhani M; Farshidfar F; Parvaneh N; Tamizifar B
    Eur J Dermatol; 2008; 18(2):159-64. PubMed ID: 18424375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid response of IgA pemphigus of the subcorneal pustular dermatosis subtype to treatment with adalimumab and mycophenolate mofetil.
    Howell SM; Bessinger GT; Altman CE; Belnap CM
    J Am Acad Dermatol; 2005 Sep; 53(3):541-3. PubMed ID: 16112379
    [No Abstract]   [Full Text] [Related]  

  • 4. Images in emergency medicine. Pemphigus vulgaris.
    Ahlers KM; Seupaul RA
    Ann Emerg Med; 2006 Apr; 47(4):395, 402. PubMed ID: 16546628
    [No Abstract]   [Full Text] [Related]  

  • 5. IgA pemphigus--occurrence of anti-desmocollin 1 and anti-desmoglein 1 antibody reactivity in an individual patient.
    Kopp T; Sitaru C; Pieczkowski F; Schneeberger A; Födinger D; Zillikens D; Stingl G; Karlhofer FM
    J Dtsch Dermatol Ges; 2006 Dec; 4(12):1045-50. PubMed ID: 17176412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pemphigus herpetiformis].
    Wosnitza M; Blazek C; Megahed M
    Hautarzt; 2008 Jun; 59(6):459-60. PubMed ID: 18470499
    [No Abstract]   [Full Text] [Related]  

  • 7. An evaluation of the usefulness of mycophenolate mofetil in pemphigus.
    Powell AM; Albert S; Al Fares S; Harman KE; Setterfield J; Bhogal B; Black MM
    Br J Dermatol; 2003 Jul; 149(1):138-45. PubMed ID: 12890207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgA pemphigus: the first two Scandinavian cases.
    Gniadecki R; Bygum A; Clemmensen O; Svejgaard E; Ullman S
    Acta Derm Venereol; 2002; 82(6):441-5. PubMed ID: 12575851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mycophenolate mofetil as effective therapy option in scarring pemphigoid].
    Elser I; Selimovic D; Ruzicka T; Kuhn A; Megahed M
    Hautarzt; 2003 Oct; 54(10):981-4. PubMed ID: 14513249
    [No Abstract]   [Full Text] [Related]  

  • 10. [Successful treatment of subcorneal pustular type of IgA pemphigus].
    Raap U; Völker B; Petering H; Hashimoto T; Zillikens D; Kapp A; Werfel T
    Hautarzt; 2005 Jan; 56(1):66-70. PubMed ID: 15580453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of pemphigus vulgaris with mycophenolate mofetil.
    Enk AH; Knop J
    Lancet; 1997 Aug; 350(9076):494. PubMed ID: 9274594
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycophenolate mofetil as a first-line steroid-sparing agent in the treatment of pemphigus vulgaris.
    Vyas N; Patel NS; Cohen GF
    J Drugs Dermatol; 2013 Feb; 12(2):210-6. PubMed ID: 23377396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcorneal pustular dermatosis-type IgA pemphigus with autoantibodies to desmocollins 1, 2, and 3.
    Düker I; Schaller J; Rose C; Zillikens D; Hashimoto T; Kunze J
    Arch Dermatol; 2009 Oct; 145(10):1159-62. PubMed ID: 19841404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgA pemphigus occurring in a 1-month-old infant.
    Suzuki M; Karube S; Kobori Y; Usui K; Murata S; Kato H; Nakagawa H
    J Am Acad Dermatol; 2003 Feb; 48(2 Suppl):S22-4. PubMed ID: 12582378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
    Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Luger TA
    Arch Dermatol; 2006 Nov; 142(11):1447-54. PubMed ID: 17116835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus.
    Doukaki S; Platamone A; Alaimo R; Bongiorno MR
    J Dermatolog Treat; 2015 Feb; 26(1):67-72. PubMed ID: 24521072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of a pemphigus with IgA and IgG antibodies and coexistent lung cancer.
    Cetkovská P; Komorousová M; Lomicová I
    Dermatol Ther; 2014; 27(4):236-9. PubMed ID: 24754245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile pemphigus foliaceus treated with sublesional corticosteroids.
    Qureshi WA; Ali A; Bhol KC; Ahmed AR
    Int J Dermatol; 1997 Nov; 36(11):848-50. PubMed ID: 9427078
    [No Abstract]   [Full Text] [Related]  

  • 19. [Open trial of mycophenolate mofetil in the treatment of resistant pemphigus vulgaris].
    Chams-Davatchi C; Nonahal Azar R; Daneshpazooh M; Valikhani M; Hallaji Z; Barzegari M; Firouz AR; Zakeri M
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):23-5. PubMed ID: 11937925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpetiform pemphigus without anti-desmoglein 1/3 autoantibodies.
    Nakashima H; Fujimoto M; Watanabe R; Ishiura N; Yamamoto AI; Hashimoto T; Tamaki K
    J Dermatol; 2010 Mar; 37(3):264-8. PubMed ID: 20507392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.